Search research articles
Contact Us
Filters
Showing results (111-120 of 161) with videos related to
Page
of 17
Sort By:
American Journal of Clinical Oncology
|
August 6, 2010
Role of androgen deprivation treatment in patients with castration-resistant prostate cancer, receiving docetaxel-based chemotherapy
Jae-Lyun Lee, Jeong Eun Kim, Jin-Hee Ahn, et al.
The Journal of Urology
|
March 18, 2014
Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging
Sang Hoon Song, Sahyun Pak, Sejun Park, et al.
European Urology Oncology
|
June 15, 2025
Stereotactic Body Radiation Therapy for Primary Renal Cancer and Genetic Markers of Response: A Phase 2 Trial
Cheryn Song, Chang Ohk Sung, Dongsu Kim, et al.
Cancer Research and Treatment
|
April 7, 2010
Efficacy and safety of docetaxel plus prednisolone chemotherapy for metastatic hormone-refractory prostate adenocarcinoma: single institutional study in Korea
Jae-Lyun Lee, Jeong Eun Kim, Jin-Hee Ahn, et al.
Journal of Cancer Research and Clinical Oncology
|
April 23, 2014
Active surveillance for metastatic or recurrent renal cell carcinoma
Inkeun Park, Jae-Lyun Lee, Jin-Hee Ahn, et al.
International Journal of Clinical and Experimental Pathology
|
January 1, 2015
VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients
Sang Hoon Song, In Gab Jeong, Dalsan You, et al.
International Journal of Clinical Oncology
|
August 6, 2011
Percent tumor volume predicts biochemical recurrence after radical prostatectomy: multi-institutional data analysis
Cheryn Song, Seongil Seo, Hanjong Ahn, et al.
Medical Oncology (Northwood, London, England)
|
March 31, 2012
Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI
Kwonoh Park, Jae-Lyun Lee, Inkeun Park, et al.
Korean Journal of Urology
|
March 13, 2015
Clinicopathological features of Xp11.2 translocation renal cell carcinoma
Bumjin Lim, Dalsan You, In Gab Jeong, et al.
Anticancer Research
|
October 3, 2014
Changes in the diffusion capacity for carbon monoxide and the development of non-infectious pneumonitis in patients with metastatic renal cell carcinoma treated with everolimus
Kwonoh Park, Hwa Jung Kim, Jae-Lyun Lee, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 161) with videos related to
Sort By:
Page
of 17
American Journal of Clinical Oncology
|
August 6, 2010
Role of androgen deprivation treatment in patients with castration-resistant prostate cancer, receiving docetaxel-based chemotherapy
Jae-Lyun Lee, Jeong Eun Kim, Jin-Hee Ahn, et al.
The Journal of Urology
|
March 18, 2014
Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging
Sang Hoon Song, Sahyun Pak, Sejun Park, et al.
European Urology Oncology
|
June 15, 2025
Stereotactic Body Radiation Therapy for Primary Renal Cancer and Genetic Markers of Response: A Phase 2 Trial
Cheryn Song, Chang Ohk Sung, Dongsu Kim, et al.
Cancer Research and Treatment
|
April 7, 2010
Efficacy and safety of docetaxel plus prednisolone chemotherapy for metastatic hormone-refractory prostate adenocarcinoma: single institutional study in Korea
Jae-Lyun Lee, Jeong Eun Kim, Jin-Hee Ahn, et al.
Journal of Cancer Research and Clinical Oncology
|
April 23, 2014
Active surveillance for metastatic or recurrent renal cell carcinoma
Inkeun Park, Jae-Lyun Lee, Jin-Hee Ahn, et al.
International Journal of Clinical and Experimental Pathology
|
January 1, 2015
VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients
Sang Hoon Song, In Gab Jeong, Dalsan You, et al.
International Journal of Clinical Oncology
|
August 6, 2011
Percent tumor volume predicts biochemical recurrence after radical prostatectomy: multi-institutional data analysis
Cheryn Song, Seongil Seo, Hanjong Ahn, et al.
Medical Oncology (Northwood, London, England)
|
March 31, 2012
Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI
Kwonoh Park, Jae-Lyun Lee, Inkeun Park, et al.
Korean Journal of Urology
|
March 13, 2015
Clinicopathological features of Xp11.2 translocation renal cell carcinoma
Bumjin Lim, Dalsan You, In Gab Jeong, et al.
Anticancer Research
|
October 3, 2014
Changes in the diffusion capacity for carbon monoxide and the development of non-infectious pneumonitis in patients with metastatic renal cell carcinoma treated with everolimus
Kwonoh Park, Hwa Jung Kim, Jae-Lyun Lee, et al.
Page
of 17